Neck News and Research

RSS

Combination of gemcitabine and cisplatin limits the progression of endometrial cancer: Study

Researchers from The University of Texas M. D. Anderson Cancer Center report that in a small study of women with advanced or recurrent endometrial cancer, gemcitabine and cisplatin, when used in combination, produced a response rate in fifty percent of patients.

18 Mar 2010

Cancer news coverage should also focus on hospice and end-of-life care

Newspaper and magazine reports about cancer appear more likely to discuss aggressive treatment and survival than death, treatment failure or adverse events, and almost none mention end-of-life palliative or hospice care, according to a report in the March 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

17 Mar 2010

PCI Biotech completes treatment of third dose group in phase I/II study of Amphinex in cancer patients

PCI Biotech reported today that it has completed the treatment of the third dose group in the phase I/II study of its proprietary photosensitiser Amphinex® used in combination with the cytotoxic agent bleomycin in cancer patients.

16 Mar 2010

Endobronchial ultrasound: More precise and less invasive than other lung cancer staging methods

A new technique being used by thoracic surgeons at Rush University Medical Center offers a more precise, less invasive and more versatile way of assessing a patient's lymph nodes and chest tumors to determine if lung cancer has spread to other parts of the body.

16 Mar 2010

New cerebral protection device prevents stroke during treatment to clear blocked carotid arteries

An important interventional radiology advancement-the use of a new cerebral protection device in combination with FDA-approved carotid stents in high-surgical-risk patients-provides a minimally invasive, safe and effective way to prevent stroke from occurring during treatment to clear blocked carotid arteries, according to research released at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla.

16 Mar 2010

UVA Health System offers Gamma Knife eXtend system to treat patients with head and neck cancer

A powerful new tool available at the University of Virginia Health System offers treatment to patients with some of the most challenging cancers of the head and neck.

16 Mar 2010

F1000 adds new Otolaryngology section to support extensive medicine coverage

Faculty of 1000 Biology, the award-winning literature awareness service for the life sciences, has launched the much anticipated Otolaryngology Faculty.

16 Mar 2010

Traumatic brain injuries may lead to life-threatening complications

One of the most common questions I am asked after someone hits their head is, "How serious is this bump on my head and should I make an appointment?" Head injuries are the result of trauma to the scalp, skull or brain. Concussion, the most common type of traumatic brain injury (TBI), is an injury that occurs after a blow to the head and results in a temporary loss of consciousness.

12 Mar 2010

In addition to anal and cervical cancer, HPV can also cause head and neck cancer

The Human Papillomavirus (HPV) is the causative agent responsible for most cases of cervical cancer, but is also associated with several other types of cancer.

12 Mar 2010

XenaCare Holdings' Cobroxin to be available for purchase in Walgreens

XenaCare Holdings, Inc., a company specializing in the marketing and retail distribution of consumer healthcare products, has announced today that its over-the-counter (OTC) pain reliever, Cobroxin, will be available for purchase in Walgreens by May 1, 2010. Walgreens is considered one of the nation’s largest pharmacy chains with 7,162 drugstores located throughout the United States.

11 Mar 2010

Small study shows eprotirome decreases LDL cholesterol

People whose "bad" cholesterol and risk of future heart disease stay too high despite cholesterol-lowering statin therapy can safely lower it by adding a drug that mimics the action of thyroid hormone. In a report published in the Mar. 11, issue of the New England Journal of Medicine, Johns Hopkins and Swedish researchers say an experimental drug called eprotirome lowered cholesterol up to 32 percent in those already on statins, an effect equal to that expected from doubling the statin drug doses, without harmful side effects.

10 Mar 2010

Astra Tech's OsseoSpeed TX implant line launched to the US market at AO Annual Meeting

Astra Tech, leading provider of comprehensive solutions for dental implant therapy, launched their OsseoSpeed™ TX implant line to the US market at this year’s AO Annual Meeting. The OsseoSpeed™ TX implant comes as the next step in the continuous evolution of the Astra Tech Implant System™ with its modified tapered apex design, first introduced with the launch of their narrow two-piece implant, OsseoSpeed™ TX 3.0 S in June 2008.

10 Mar 2010

Idera Pharmaceuticals announces net income of $3.9M for fourth-quarter 2009

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2009.

10 Mar 2010

Clinical and scientific advances made in the field of neuro-oncology

Many important clinical and basic scientific advances have been made in the past five years in the field of neuro-oncology, according to an editorial and several articles in the March issue of Archives of Neurology, one of the JAMA/Archives journals.

9 Mar 2010

Porter Adventist Hospital designated as Blue Distinction Center for spine surgery, knee and hip replacement programs

Porter Adventist Hospital is among the first in the country to receive designation as Blue Distinction Centers in two surgical services that have recently been added to the Blue Cross and Blue Shield Association's expansion of its Blue Distinction® designation.

5 Mar 2010

People with skin of color more prone to dermatologic problems than those with lighter skin tones

According to projections from the United States Census Bureau, people with skin of color will comprise approximately half of the U.S. population by 2050. This group, which includes African-Americans, Asians, Latinos and other ethnicities, are more prone to certain dermatologic problems than those with lighter skin tones due to their genetic make-up and in some cases cultural practices.

5 Mar 2010

bioTheranostics launches CancerTYPE ID database and KRAS mutational testing

bioTheranostics, a bioMerieux company that discovers, develops and commercializes innovative molecular diagnostic tests in oncology, announces the launch of an expanded tumor-type database for its flagship product, CancerTYPE ID®, and the launch of KRAS mutational testing.

5 Mar 2010

Top ten beauty treatments

RoxSpa, one of the most prestigious and luxurious medi-spas in Beverly Hills, announces their annual 'Top Ten' face and body rejuvenation treatments that are both highly-effective and provide the most satisfying results.

4 Mar 2010

Allergan celebrates 20th anniversary of BOTOX in Canada

Twenty years ago, the first approved use of BOTOX(R) (botulinum toxin type A), a neurotoxin widely used to treat several life altering medical conditions, was granted in Canada. As part of the 20th anniversary celebrations, healthcare professionals from coast to coast reflect upon the discovery, science and evolution of a therapy that has impacted the lives of millions of patients worldwide.

3 Mar 2010

National Cancer Institute awards PDS Biotechnology $1.28M phase 2 SBIR contract

PDS Biotechnology Corporation today announced that the company has been awarded a $1.28M phase 2 SBIR contract by the National Cancer Institute division of the US National Institutes of Health. The contract provides funding to complete studies required to file an Investigational New Drug Application (IND) with the FDA for the company's lead human papillomavirus (HPV)-cancer product late in 2010.

2 Mar 2010

Neck News and Research

Combination of gemcitabine and cisplatin limits the progression of endometrial cancer: Study

Cancer news coverage should also focus on hospice and end-of-life care

PCI Biotech completes treatment of third dose group in phase I/II study of Amphinex in cancer patients

Endobronchial ultrasound: More precise and less invasive than other lung cancer staging methods

New cerebral protection device prevents stroke during treatment to clear blocked carotid arteries

UVA Health System offers Gamma Knife eXtend system to treat patients with head and neck cancer

F1000 adds new Otolaryngology section to support extensive medicine coverage

Traumatic brain injuries may lead to life-threatening complications

In addition to anal and cervical cancer, HPV can also cause head and neck cancer

XenaCare Holdings' Cobroxin to be available for purchase in Walgreens

Small study shows eprotirome decreases LDL cholesterol

Astra Tech's OsseoSpeed TX implant line launched to the US market at AO Annual Meeting

Idera Pharmaceuticals announces net income of $3.9M for fourth-quarter 2009

Clinical and scientific advances made in the field of neuro-oncology

Porter Adventist Hospital designated as Blue Distinction Center for spine surgery, knee and hip replacement programs

People with skin of color more prone to dermatologic problems than those with lighter skin tones

bioTheranostics launches CancerTYPE ID database and KRAS mutational testing

Top ten beauty treatments

Allergan celebrates 20th anniversary of BOTOX in Canada

National Cancer Institute awards PDS Biotechnology $1.28M phase 2 SBIR contract

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News